Valuation: Recordati

Capitalization 10.33B 12.03B 9.46B 8.98B 16.53B 1,159B 16.82B 113B 43.86B 548B 45.14B 44.18B 1,911B P/E ratio 2026 *
20.5x
P/E ratio 2027 * 17.1x
Enterprise value 12.13B 14.12B 11.1B 10.54B 19.41B 1,360B 19.74B 133B 51.48B 643B 52.98B 51.86B 2,243B EV / Sales 2026 *
4.36x
EV / Sales 2027 * 3.93x
Free-Float
50.92%
Yield 2026 *
3.02%
Yield 2027 * 3.33%
1 day+0.10%
1 week+2.07%
Current month+2.44%
1 month+1.40%
3 months+6.78%
6 months+1.29%
Current year+4.76%
1 week 49.32
Extreme 49.32
52.55
1 month 48.9
Extreme 48.9
52.55
Current year 43.76
Extreme 43.76
52.55
1 year 43.76
Extreme 43.76
55.35
3 years 40.62
Extreme 40.62
60.95
5 years 34.52
Extreme 34.52
60.95
10 years 24.24
Extreme 24.24
60.95
Manager TitleAgeSince
Chief Executive Officer 63 30/11/2021
Director of Finance/CFO 56 31/12/2025
Chief Tech/Sci/R&D Officer 56 30/09/2023
Director TitleAgeSince
Chairman 54 30/11/2021
Chairman 57 11/06/2018
Director/Board Member 53 11/06/2018
Change 5d. change 1-year change 3-years change Capi.($)
+0.10%+2.07%-1.17%+13.00% 12.03B
-1.67%+2.18%+30.46%+125.65% 881B
+0.97%+3.38%+51.27%+44.45% 551B
-0.47%+3.27%+13.80%+45.99% 370B
+1.67%+1.06%+24.30%+13.90% 327B
+1.30%+2.36%+29.59%+31.08% 284B
+1.04%+0.55%+33.28%+15.10% 285B
+1.06%+1.15%+47.99%-1.26% 278B
+0.26%-3.52%-34.80%-51.51% 197B
-0.59%-1.58%+19.08%+44.67% 175B
Average +0.55%+1.16%+21.38%+28.11% 336.07B
Weighted average by Cap. +0.45%+1.70%+28.51%+49.80%

Financials

2026 *2027 *
Net sales 2.78B 3.24B 2.55B 2.42B 4.45B 312B 4.53B 30.46B 11.81B 148B 12.15B 11.89B 514B 3.01B 3.5B 2.75B 2.62B 4.82B 338B 4.9B 32.97B 12.78B 160B 13.15B 12.87B 557B
Net income 554M 645M 507M 482M 887M 62.14B 902M 6.07B 2.35B 29.4B 2.42B 2.37B 102B 658M 766M 602M 572M 1.05B 73.79B 1.07B 7.21B 2.79B 34.91B 2.87B 2.81B 122B
Net Debt 1.8B 2.09B 1.64B 1.56B 2.87B 201B 2.92B 19.66B 7.62B 95.24B 7.84B 7.68B 332B 1.5B 1.74B 1.37B 1.3B 2.39B 168B 2.43B 16.38B 6.35B 79.37B 6.53B 6.4B 277B
Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (58.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (41.3%). Net sales are distributed geographically as follows: Italy (12.6%), Europe (53.7%), America (23.1%), Asia and Oceania (7.8%) and Africa (2.8%).
Employees
4,654
Date Price Change Volume
19/05/26 50.85 +0.10% 106,039
18/05/26 50.80 -1.36% 434,748
15/05/26 51.50 -0.58% 359,572
14/05/26 51.80 0.00% 390,338
13/05/26 51.80 +3.97% 1,018,577
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
50.80EUR
Average target price
59.09EUR
Spread / Average Target
+16.32%

Quarterly revenue - Rate of surprise